Therapeutic doses of irradiation activate viral transcription and induce apoptosis in HIV-1 infected cells

Virology. 2015 Nov:485:1-15. doi: 10.1016/j.virol.2015.06.021. Epub 2015 Jul 14.

Abstract

The highly active antiretroviral therapy reduces HIV-1 RNA in plasma to undetectable levels. However, the virus continues to persist in the long-lived resting CD4(+) T cells, macrophages and astrocytes which form a viral reservoir in infected individuals. Reactivation of viral transcription is critical since the host immune response in combination with antiretroviral therapy may eradicate the virus. Using the chronically HIV-1 infected T lymphoblastoid and monocytic cell lines, primary quiescent CD4(+) T cells and humanized mice infected with dual-tropic HIV-1 89.6, we examined the effect of various X-ray irradiation (IR) doses (used for HIV-related lymphoma treatment and lower doses) on HIV-1 transcription and viability of infected cells. Treatment of both T cells and monocytes with IR, a well-defined stress signal, led to increase of HIV-1 transcription, as evidenced by the presence of RNA polymerase II and reduction of HDAC1 and methyl transferase SUV39H1 on the HIV-1 promoter. This correlated with the increased GFP signal and elevated level of intracellular HIV-1 RNA in the IR-treated quiescent CD4(+) T cells infected with GFP-encoding HIV-1. Exposition of latently HIV-1infected monocytes treated with PKC agonist bryostatin 1 to IR enhanced transcription activation effect of this latency-reversing agent. Increased HIV-1 replication after IR correlated with higher cell death: the level of phosphorylated Ser46 in p53, responsible for apoptosis induction, was markedly higher in the HIV-1 infected cells following IR treatment. Exposure of HIV-1 infected humanized mice with undetectable viral RNA level to IR resulted in a significant increase of HIV-1 RNA in plasma, lung and brain tissues. Collectively, these data point to the use of low to moderate dose of IR alone or in combination with HIV-1 transcription activators as a potential application for the "Shock and Kill" strategy for latently HIV-1 infected cells.

Keywords: Apoptosis; CD4+ T cells; HIV-1 latency; HIV-1 reactivation; Humanized mice; Irradiation; Monocytes; Transcription; X-ray.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Anti-HIV Agents / pharmacology
  • Apoptosis / radiation effects*
  • Bryostatins / pharmacology
  • CD4-Positive T-Lymphocytes
  • Cell Line, Tumor
  • Cell Survival
  • Female
  • Gamma Rays / therapeutic use*
  • Genes, Reporter
  • Green Fluorescent Proteins / genetics
  • Green Fluorescent Proteins / metabolism
  • HIV Infections / drug therapy
  • HIV Infections / genetics
  • HIV Infections / radiotherapy*
  • HIV Infections / virology
  • HIV-1 / physiology
  • HIV-1 / radiation effects*
  • Histone Deacetylase 1 / genetics
  • Histone Deacetylase 1 / metabolism
  • Humans
  • Male
  • Methyltransferases / genetics
  • Methyltransferases / metabolism
  • Mice
  • Monocytes
  • RNA Polymerase II / genetics
  • RNA Polymerase II / metabolism
  • RNA, Viral / agonists
  • RNA, Viral / genetics
  • RNA, Viral / metabolism
  • Repressor Proteins / agonists
  • Repressor Proteins / genetics
  • Repressor Proteins / metabolism
  • Transcription, Genetic / radiation effects*
  • Tumor Suppressor Protein p53 / agonists
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / metabolism
  • Virus Activation / radiation effects
  • Virus Replication / radiation effects

Substances

  • Anti-HIV Agents
  • Bryostatins
  • RNA, Viral
  • Repressor Proteins
  • Tumor Suppressor Protein p53
  • Green Fluorescent Proteins
  • bryostatin 1
  • SUV39H1 protein, human
  • Methyltransferases
  • RNA Polymerase II
  • HDAC1 protein, human
  • Histone Deacetylase 1